Neurocrine Biosciences NBIX
$ 126.18
-0.65%
Quarterly report 2024-Q3
added 10-30-2024
Country |
USA |
IPO year |
1996 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Kevin Gorman |
Employees in the company |
825 |
Shares |
97.7 M |
Market Cap[1] |
$ 12.3 B |
EBITDA (LTM) |
$ 148 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.